Floatz logo

Jskn016

Locally Advanced Breast Cancer (LABC)

Jiangsu Alphamab Biopharmaceuticals Co., LtdPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Locally Advanced Breast Cancer (LABC) cohort.

Asset / SponsorPhaseRating
CONTUSUGENE LADENOVEC
Phase 2B
Biottt001
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Phase 1CC

Same molecule, other indications

Jskn016 is also rated in:

non-small cell lung carcinomaDormant
B
Indicative ·
58 / 100
View asset →
triple-negative breast carcinomaDormant
CCC
Indicative ·
52 / 100
View asset →
breast cancerDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →